drugset / Trial / NCT00862381

Hydrocortisone Use After Etomidate in Intensive Care

NCT00862381

Phase 3 Completed 106 enrolled University Hospital, Grenoble
RandomizedParallel-groupQuadruple-blindTreatment

Summary

the objective of the study is to assess the value of substitution with 200mg/24h of hydrocortisone for 48 hours for patients in intensive care who have received a single injection of etomidate

Timeline

Start
2008-10
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 200 mg Other

Indications

No indication recorded.